First Prospective Multicenter Italian Study on the Impact of the 21‐Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer

BACKGROUND. The Breast DX Italy prospective study evaluated the impact of the 21‐gene recurrence score (RS) result on adjuvant treatment decisions for patients with early breast cancer. MATERIALS AND METHODS. Nine centers (two Hub and seven Spoke centers of the Veneto Oncology Network) participated....

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncologist
Hoofdauteurs: Dieci, Maria Vittoria, Guarneri, Valentina, Giarratano, Tommaso, Mion, Marta, Tortora, Giampaolo, De Rossi, Costanza, Gori, Stefania, Oliani, Cristina, Merlini, Laura, Pasini, Felice, Bonciarelli, Giorgio, Griguolo, Gaia, Orvieto, Enrico, Michieletto, Silvia, Saibene, Tania, Del Bianco, Paola, De Salvo, Gian Luca, Conte, PierFranco
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: AlphaMed Press 2017
Onderwerpen:
Breast Cancer
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5905682/
https://ncbi.nlm.nih.gov/pubmed/29133514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0322
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items